Mitochondrial Involvement in Brain Function and Dysfunction: Relevance to Aging, Neurodegenerative Disorders and Longevity
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Neurochemical Research
- Vol. 26 (6) , 739-764
- https://doi.org/10.1023/a:1010955807739
Abstract
It is becoming increasingly evident that the mitochondrial genome may play a key role in neurodegenerative diseases. Mitochondrial dysfunction is characteristic of several neurodegenerative disorders, and evidence for mitochondria being a site of damage in neurodegenerative disorders is partially based on decreases in respiratory chain complex activities in Parkinson's disease, Alzheimer's disease, and Huntington's disease. Such defects in respiratory complex activities, possibly associated with oxidant/antioxidant balance perturbation, are thought to underlie defects in energy metabolism and induce cellular degeneration. Efficient functioning of maintenance and repair process seems to be crucial for both survival and physical quality of life. This is accomplished by a complex network of the so-called longevity assurance processes, which are composed of genes termed vitagenes. A promising approach for the identification of critical gerontogenic processes is represented by the hormesis-like positive effect of stress. In the present review, we discuss the role of energy thresholds in brain mitochondria and their implications in neurodegeneration. We then review the evidence for the role of oxidative stress in modulating the effects of mitochondrial DNA mutations on brain age-related disorders and also discuss new approaches for investigating the mechanisms of lifetime survival and longevity.Keywords
This publication has 99 references indexed in Scilit:
- Attenuated c-fos mRNA Induction after Middle Cerebral Artery Occlusion in CREB Knockout Mice Does Not Modulate Focal Ischemic InjuryJournal of Cerebral Blood Flow & Metabolism, 1998
- Mitochondrial Decay in Aging: Reversal through Supplementation of Acetyl‐l‐Carnitine and N‐tert‐Butyl‐α‐phenyl‐nitroneaAnnals of the New York Academy of Sciences, 1998
- Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsyAnnals of Neurology, 1998
- Alzheimer's disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproductsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- Network theory of agingExperimental Gerontology, 1997
- Spatial memory and NGF levels in aged rats: Natural variability and effects of acetyl-l-carnitine treatmentExperimental Gerontology, 1996
- Oxidative damage in Alzheimer'sNature, 1996
- Increased cortical nuclear factor-κB (NF-κB) DNA binding activity after traumatic brain injury in ratsNeuroscience Letters, 1995
- The mitochondrial permeability transitionBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysisBiochemical and Biophysical Research Communications, 1990